PT Pyridam Farma Tbk (PYFA.JK)
IDR 208.0
(-3.7%)
IDR 208.0
(-3.7%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1164.17 Billion IDR | 7.97% |
| 2022 | 1078.21 Billion IDR | 68.7% |
| 2021 | 639.12 Billion IDR | 800.89% |
| 2020 | 70.94 Billion IDR | 7.39% |
| 2019 | 66.06 Billion IDR | -3.04% |
| 2018 | 68.12 Billion IDR | 34.36% |
| 2017 | 50.7 Billion IDR | -17.62% |
| 2016 | 61.55 Billion IDR | 4.81% |
| 2015 | 58.72 Billion IDR | -22.17% |
| 2014 | 75.46 Billion IDR | -7.09% |
| 2013 | 81.21 Billion IDR | 68.7% |
| 2012 | 48.14 Billion IDR | 35.1% |
| 2011 | 35.63 Billion IDR | 52.54% |
| 2010 | 23.36 Billion IDR | -13.19% |
| 2009 | 26.91 Billion IDR | -8.47% |
| 2008 | 29.4 Billion IDR | 4.21% |
| 2007 | 28.21 Billion IDR | 57.38% |
| 2006 | 17.92 Billion IDR | 37.06% |
| 2005 | 13.07 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1600.44 Billion IDR | 37.48% |
| 2024 Q3 | 4693.92 Billion IDR | -2.47% |
| 2024 Q2 | 4812.6 Billion IDR | 200.7% |
| 2023 Q4 | 1164.17 Billion IDR | 0.24% |
| 2023 Q1 | 1058.12 Billion IDR | -1.86% |
| 2023 Q2 | 1109.37 Billion IDR | 4.84% |
| 2023 FY | 1164.17 Billion IDR | 7.97% |
| 2023 Q3 | 1161.39 Billion IDR | 4.69% |
| 2022 Q2 | 1047.78 Billion IDR | -2.45% |
| 2022 FY | 1078.21 Billion IDR | 68.7% |
| 2022 Q4 | 1078.21 Billion IDR | 1.63% |
| 2022 Q1 | 1074.13 Billion IDR | 68.06% |
| 2022 Q3 | 1060.91 Billion IDR | 1.25% |
| 2021 Q3 | 444.58 Billion IDR | 10.22% |
| 2021 Q2 | 403.35 Billion IDR | -0.18% |
| 2021 Q1 | 404.08 Billion IDR | 469.59% |
| 2021 FY | 639.12 Billion IDR | 800.89% |
| 2021 Q4 | 639.12 Billion IDR | 43.76% |
| 2020 Q1 | 75.95 Billion IDR | 14.98% |
| 2020 FY | 70.94 Billion IDR | 7.39% |
| 2020 Q4 | 70.94 Billion IDR | -8.77% |
| 2020 Q3 | 77.76 Billion IDR | 9.83% |
| 2020 Q2 | 70.8 Billion IDR | -6.78% |
| 2019 Q3 | 68.02 Billion IDR | 3.25% |
| 2019 Q4 | 66.06 Billion IDR | -2.9% |
| 2019 Q2 | 65.89 Billion IDR | -6.53% |
| 2019 FY | 66.06 Billion IDR | -3.04% |
| 2019 Q1 | 70.49 Billion IDR | 3.47% |
| 2018 Q1 | 72.7 Billion IDR | 43.39% |
| 2018 FY | 68.12 Billion IDR | 34.36% |
| 2018 Q4 | 68.12 Billion IDR | -8.3% |
| 2018 Q3 | 74.29 Billion IDR | 0.08% |
| 2018 Q2 | 74.23 Billion IDR | 2.1% |
| 2017 FY | 50.7 Billion IDR | -17.62% |
| 2017 Q2 | 60.46 Billion IDR | -2.3% |
| 2017 Q1 | 61.88 Billion IDR | 0.54% |
| 2017 Q3 | 54.92 Billion IDR | -9.15% |
| 2017 Q4 | 50.7 Billion IDR | -7.68% |
| 2016 Q3 | 56.06 Billion IDR | -11.14% |
| 2016 Q1 | 60.47 Billion IDR | 2.98% |
| 2016 FY | 61.55 Billion IDR | 4.81% |
| 2016 Q4 | 61.55 Billion IDR | 9.79% |
| 2016 Q2 | 63.09 Billion IDR | 4.33% |
| 2015 Q3 | 73.06 Billion IDR | -4.87% |
| 2015 FY | 58.72 Billion IDR | -22.17% |
| 2015 Q1 | 76.43 Billion IDR | 1.29% |
| 2015 Q2 | 76.8 Billion IDR | 0.48% |
| 2015 Q4 | 58.72 Billion IDR | -19.62% |
| 2014 Q4 | 75.46 Billion IDR | -0.47% |
| 2014 FY | 75.46 Billion IDR | -7.09% |
| 2014 Q3 | 75.81 Billion IDR | -3.69% |
| 2014 Q2 | 78.72 Billion IDR | -8.72% |
| 2014 Q1 | 86.24 Billion IDR | 6.19% |
| 2013 FY | 81.21 Billion IDR | 68.7% |
| 2013 Q2 | 69.45 Billion IDR | 32.27% |
| 2013 Q3 | 77.73 Billion IDR | 11.92% |
| 2013 Q4 | 81.21 Billion IDR | 4.49% |
| 2013 Q1 | 52.51 Billion IDR | 9.07% |
| 2012 Q1 | 34.39 Billion IDR | -3.49% |
| 2012 FY | 48.14 Billion IDR | 35.1% |
| 2012 Q2 | 36.03 Billion IDR | 4.78% |
| 2012 Q3 | 44.68 Billion IDR | 23.99% |
| 2012 Q4 | 48.14 Billion IDR | 7.75% |
| 2011 Q4 | 35.63 Billion IDR | 0.0% |
| 2011 FY | 35.63 Billion IDR | 52.54% |
| 2010 FY | 23.36 Billion IDR | -13.19% |
| 2009 FY | 26.91 Billion IDR | -8.47% |
| 2008 FY | 29.4 Billion IDR | 4.21% |
| 2007 FY | 28.21 Billion IDR | 57.38% |
| 2006 FY | 17.92 Billion IDR | 37.06% |
| 2005 FY | 13.07 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 639.05 Billion IDR | -82.172% |
| PT Merck Tbk | 161.93 Billion IDR | -618.912% |
| PT Phapros, Tbk | 995.56 Billion IDR | -16.936% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 504.76 Billion IDR | -130.637% |
| PT Tempo Scan Pacific Tbk | 3250.09 Billion IDR | 64.18% |